Specialty Sales

• Cardiology
• Dermatology
• Endocrinology
• Infectious disease

• Nephrology
• Neurology
• Oncology
• Radiology

• Ophthalmology
• Pediatrics
• Substance abuse specialists

When Smaller is Better

As the industry turns its attention toward specialty products in the hopes of filling drying pipelines, smaller pharma and biotech companies may find themselves in the drivers seat..

Download Page

Appeared in September 2008 PharmaVoice. Used with Permission.

Bigger Managed Markets Voice For Big Pharma Company

Solutions Attain 100% Or Better Of Targeted Goals

PSSG's sales and marketing strategies achieved 100% or more of the targeted goals for a top pharmaceutical company's 8 under-represented specialty products while also expanding into new managed market channels. To learn more about how PSSG increased the share of voice for all 8 products, Click here.

Case Study #7003-MM

Unique Specialty Product Launch

Commercialization Achieves 262% Sales Increase

Launching a product is a daunting challenge for any marketing team, but imagine the difficulty of launching a new brand with little infrastructure and few resources. To learn how Publicis Selling Solutions helped an emerging specialty company do it right, click here.

Case Study #7001-CS

Putting The 'Smart' In Smart Deployment

Biotech Drug Utilization: Twice the Results For Only 20% Of Competitor's Cost

At only 20% of the cost of its competitor's initiative, Publicis Selling Solutions' smart deployment of a regional expansion for a biotech company's chronic kidney disease treatment more than doubled its utilization. To learn more about our cost-effective approach, click here.

Case Study #7004-CKD